High prevalence of sleep apnea syndrome in patients admitted to ICU for acute hypercapnic respiratory failure: a preliminary study

2017 ◽  
Vol 44 (2) ◽  
pp. 267-269 ◽  
Author(s):  
Arnaud W. Thille ◽  
Ana Córdoba-Izquierdo ◽  
Bernard Maitre ◽  
Laurent Boyer ◽  
Laurent Brochard ◽  
...  
2012 ◽  
Vol 13 (7) ◽  
pp. 852-858 ◽  
Author(s):  
Claire Fuhrman ◽  
Bernard Fleury ◽  
Xuân-Lan Nguyên ◽  
Marie-Christine Delmas

2013 ◽  
Vol 2013 ◽  
pp. 1-7 ◽  
Author(s):  
Kazuya Fujihara ◽  
Satoru Kodama ◽  
Chika Horikawa ◽  
Sakiko Yoshizawa ◽  
Ayumi Sugawara ◽  
...  

Aims. High prevalence of sleep apnea syndrome (SAS) has been reported in patients with diabetes. However, whether diabetic neuropathy (DN) contributes to this high prevalence is controversial. Our aim of this study is to compare the prevalence of SAS between patients with and without DN.Methods. Systematic literature searches were conducted for cross-sectional studies that reported the number of patients with DN and SAS using MEDLINE (from 1966 to Nov 5, 2012) and EMBASE (from 1974 to Nov 5, 2012). Odds ratios (ORs) of SAS related to DN were pooled with the Mantel-Haenszel method.Results. Data were obtained from 5 eligible studies (including 6 data sets, 880 participants, and 429 cases). Overall, the pooled OR of SAS in patients with DN compared with that in non-DN patients was significant (OR (95% CI), −1.95 (1.03–3.70)). The pooled OR of SAS was 1.90 (0.97–3.71) in patients with type 2 diabetes. Excluding data on patients with type 1 diabetes, a higher OR was observed in younger patients (mean age <60 years) than in those ≥60 years among whom the OR remained significant (3.82; 95% CI, 2.24–6.51 and 1.17; 95% CI, 0.81–1.68).Conclusions. Current meta-analysis suggested the association of some elements of neuropathy with SAS in type 2 diabetes. Further investigations are needed to clarify whether the association is also true for patients with type 1 diabetes.


Sign in / Sign up

Export Citation Format

Share Document